ANNE WARD: Open Payments
NPI 1952858938 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 28 payments from 10 companies in 2025. Trend: 2023 $1,047 · 2024 $1,538 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $208 |
| Alnylam Pharmaceuticals Inc. | 5 | $176 |
| SCPHARMACEUTICALS INC. | 1 | $122 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: VYNDAQEL, AMVUTTRA, FUROSCIX, Tryvio, Attruby, REPATHA, Wegovy, ELIQUIS.
Industry payments across AL — which companies pay providers there.
